Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2020) 70 AEP934 | DOI: 10.1530/endoabs.70.AEP934

ECE2020 Audio ePoster Presentations Thyroid (144 abstracts)

Myasthenia gravis associated with Graves’ disease: About three cases

Marwa majdoub 1 , Imen Rojbi 2 , Sabrine Mekni 2 , Nadia Mchirgui 2 , Ibtissem Ben Nacef 2 & Karima Khiari 2


1Charles Nicolle Hospital, Endocrinology, Tunis, Tunisia; 2Charles Nicolle Hospitalt, Tunis, Tunisia


Introduction: The coexistence of Grave disease [GD] and Myasthenia gravis [MG] may present a diagnostic dilemma especially concerning ocular manifestations. 3–10% of myasthenic patients exhibit GD, while MG is reported in only <1% of patients with thyroid disorder.

Observation:

Case 1: A 32-year-old woman, with a medical history of vitiligo, was diagnosed with GD. Immunology revealed positive anti-thyroid peroxidase antibodies [TPOAb] and TSH receptor antibodies [TRAb]. Treatment with Anti-thyroid drugs was soon withdrawn because of severe eruption and the patient received radical treatment (I-131). Two months later, she reconsulted for muscle use increasing throughout the day. The diagnosis of MG was confirmed by a Prostigmine test, and positive Acetylcholine receptors [AChR] antibodies. The treatment with Pyridostigmine was immediately initiated. But, the amplification of myastenic symptoms later led to successive immuneglobulin cures.

Case 2: A 43-year-old man consulted for exophthalmia, diplopia, asymmetric ptosis and blurring of vision. Physical examination demonstrated a goiter, a resting tremor and proximal muscle weakness. Thyroid function test showed high levels of thyroid hormones, TSH < 0.05. Both GD with severe ophthalmopathy and MG were suspected. Immunology confirmed the diagnoses, with positive TRAb, TPOAb and AChR antibodies. The patient was started on Thiamazol and Pyridostigmine, with a good evolution.

Case 3: A 41-year-old woman complaining of asthenia by the end of the day, diplopia and difficulty chewing. She reported a medical history of GD treated for 2 years with Benzylthiouracil, then Radioiodine at the age of 28. AChR antibodies and Anti-striated muscle Antibodies were positive confirming MG’s diagnosis, with a thymic tumor revealed on chest scan. Therefore, the patient underwent a total thymectomy that in association with cholinesterase inhibitors was fairly efficient.

Conclusion: GD is associated with a number of autoimmune diseases, including myasthenia. Two out of our three patients had ocular myasthenic symptoms. Thyroid disease was found to be more frequent in ocular MG patients (40%) than in generalized MG patients (12%). Accordingly, it is important for every endocrinologist to suspect the association of MG in each GD patient especially on the presence of ptosis, exotropia, muscle weakness increasing with exercise.

Volume 70

22nd European Congress of Endocrinology

Online
05 Sep 2020 - 09 Sep 2020

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.